Compare Cipta Sarana Medika Tbk. (DKHH) vs Trimegah Karya Pratama Tbk. (UVCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 163.22B, 2.44M 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp143 (market cap 292.02B, 10.68M 24h volume). The key difference: Trimegah Karya Pratama Tbk. is the larger of the two by market cap, and Trimegah Karya Pratama Tbk. is more actively traded (10.68M versus 2.44M). Which is the better fit depends on your goals.
| DKHH | UVCR | |
|---|---|---|
Market Cap | 163.22B | 292.02B |
Volume | 2.44M | 10.68M |
Lot | 24.43K | 106.82K |
Turnover | 155.81M | 1.54B |
Average Price | 63.78 | 144.06 |
Value | 155.81M | 1.54B |
Indicative Equilibrium Price | 64 | 146 |
Indicative Equilibrium Volume | 110.6K | 117.3K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Trimegah Karya Pratama Tbk.
PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →
